Same-day Cervical Preparation Before Dilation and Evacuation
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 8/16/2018 |
Start Date: | December 2016 |
End Date: | December 2019 |
Contact: | Research Director, MPH |
Email: | ctri@ppnyc.org |
Same-day Cervical Preparation With Dilapan-S™ Plus Buccal Misoprostol Compared to Overnight Dilapan-S™ Before Dilation and Evacuation at 16 to 20 Weeks' Gestation: A Randomized Controlled Trial
The purpose of this randomized trial is to compare same-day cervical preparation using
Dilapan-S™ plus buccal misoprostol to overnight cervical preparation using Dilapan-S™ before
D&E at 16.0 to 20.0 weeks.
Primary objective: To compare D&E operative time. We hypothesize that same-day Dilapan-S™
plus buccal misoprostol is non-inferior to overnight Dilapan-S™ with respect to operative
time.
Secondary objectives: To compare treatment groups for the following: Pre-operative cervical
dilation; need for mechanical dilation and ease of dilation if required; ability to complete
D&E without further cervical preparation; ease of D&E; complications; pain; side effects;
patient and provider satisfaction.
Dilapan-S™ plus buccal misoprostol to overnight cervical preparation using Dilapan-S™ before
D&E at 16.0 to 20.0 weeks.
Primary objective: To compare D&E operative time. We hypothesize that same-day Dilapan-S™
plus buccal misoprostol is non-inferior to overnight Dilapan-S™ with respect to operative
time.
Secondary objectives: To compare treatment groups for the following: Pre-operative cervical
dilation; need for mechanical dilation and ease of dilation if required; ability to complete
D&E without further cervical preparation; ease of D&E; complications; pain; side effects;
patient and provider satisfaction.
Inclusion Criteria:
- 18 years of age and older
- Seeking pregnancy termination from 16 0/7 to 19 6/7 weeks of gestation on the day of
enrollment.
- Eligible for pregnancy termination at PPNYC
- Able to give informed consent
- English speaking
Exclusion Criteria:
- Active bleeding or hemodynamically unstable at enrollment
- Signs of chorioamnionitis or clinical infection at enrollment
- Signs of spontaneous labor or cervical insufficiency at enrollment
- Spontaneous intrauterine fetal demise
- Allergy to Dilapan-S™ or misoprostol
We found this trial at
1
site
Click here to add this to my saved trials